|
CTSF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.21858079182857E-12 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.66933133982639E-12 |
| Stage1-vs-Stage2 |
1.661560E-01 |
| Stage1-vs-Stage3 |
5.979800E-01 |
| Stage1-vs-Stage4 |
2.175200E-01 |
| Stage2-vs-Stage3 |
3.658200E-01 |
| Stage2-vs-Stage4 |
8.706200E-01 |
| Stage3-vs-Stage4 |
4.421400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
7.00799995811963E-09 |
| Normal-vs-Asian |
1.19109999641154E-08 |
| Caucasian-vs-AfricanAmerican |
9.950000E-01 |
| Caucasian-vs-Asian |
5.418400E-02 |
| AfricanAmerican-vs-Asian |
1.835010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.416020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
2.55351295663786E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.76429999998451E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.616200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.179210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.661000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.806290E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.154800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.714400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.392590E-01 |
| Classical-VS-Follicular |
5.55660000234326E-08 |
| Classical-VS-Other |
6.362000E-01 |
| Classical-VS-Normal |
1.62470037423645E-12 |
| Tall-VS-Follicular |
3.545800E-02 |
| Tall-VS-Other |
9.041600E-01 |
| Tall-VS-Normal |
1.08609787830005E-11 |
| Follicular-VS-Other |
2.134200E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
1.990370E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.01838545876853E-13 |
| N0-vs-N1 |
4.713000E-01 |
|
|
